SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, developer of the Twintelligent RCT™, today announced that the company has entered into a multi-year collaboration with Merck KGaA, Darmstadt, Germany to ...
Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...
Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...
The idea of digital twins -- digital representations of humans built with computer models -- for medical research is gaining traction in private and academic sectors. With predictive simulation ...
Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...
A colleague recently said to me, “Unlearning is the new learning.” I laughed and rolled my eyes given it sounded…well…kind of dumb. But then, we got to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results